Physician profile
Alexander Sapp
NPI 1467831305
$5,765.32
in general payments reported to CMS, 2019-2025
30 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $1,024 · 2022: $1,767 · 2023: $1,078 · 2024: $634 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,866.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,018.36 | 2021-2025 | Hawkone, Endurant Iis, Spiderfx |
| W. L. Gore & Associates, INC. | $1,157.36 | 2022-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $638.77 | 2021-2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Peripheral Rotalink Plus |
| Silk Road Medical, INC. | $533.06 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $301.91 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $195.15 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Getinge USA Sales, LLC | $125.00 | 2021 | |
| Avanos Medical | $76.69 | 2019 | |
| Penumbra, INC. | $71.67 | 2025 | Indigo System |
| Stryker Corporation | $71.52 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Imperative Care, INC | $66.56 | 2025 | Prodigy Catheter |
| Baxter Healthcare | $61.52 | 2023-2024 | Preveleak |
| Cardiovascular Systems INC. | $49.89 | 2022-2023 | Diamondback Peripheral |
| Abbott Laboratories | $38.80 | 2023-2024 | Diamondback Peripheral |
| Cardiva Medical, INC. | $34.25 | 2024 | Cardiva Vascade 6/7f Vcs |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $31.12 | 2024 | Ultomiris |
| Vertex Pharmaceuticals Incorporated | $29.64 | 2025 | |
| Solventum Corporation | $27.40 | 2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Bolton Medical INC | $26.46 | 2024 | |
| Lemaitre Vascular, INC. | $24.62 | 2025 | Artegraft Vascular Graft |
| Cook Medical LLC | $22.69 | 2024 | Cook, Zenith |
| Reflow Medical INC | $22.54 | 2024 | |
| Cordis US Corp. | $21.76 | 2025 | |
| Bard Peripheral Vascular, INC. | $19.52 | 2024 | Fluency Endovascular Stent Graft |
| Globus Medical, INC. | $18.93 | 2025 | Senza |
| Tactile Systems Technology INC | $18.48 | 2025 | Flexitouch Plus, Nimbl |
| Shire North American Group INC | $17.01 | 2019 | |
| Chiesi USA, INC. | $16.94 | 2023 | Kengreal, Cleviprex |
| Surmodics, INC. | $14.00 | 2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Pfizer INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Sapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.